Indication
Growth Hormone Disorder
2 clinical trials
4 products
Clinical trial
Randomized Cross Over Double Blind Versus Placebo Trial Followed by an Open Phase Studying Effect of Norditropin® on Left Ventricular Mass of Growth Hormone Deficient Adult PatientsStatus: Completed, Estimated PCD: 2002-12-01
Product
placeboProduct
somatropinProduct
somapacitanProduct
Norditropin FlexProClinical trial
A Randomised, Multinational, Active-controlled, (Open-labelled), Dose Finding, (Double-blinded), Parallel Group Trial Investigating Efficacy and Safety of Once-weekly NNC0195-0092 Treatment Compared to Daily Growth Hormone Treatment (Norditropin® FlexPro®) in Growth Hormone Treatment naïve Pre-pubertal Children With Growth Hormone DeficiencyStatus: Recruiting, Estimated PCD: 2024-08-26